Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × camrelizumab × Clear all

NCT04068974 2021-03-16

Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms